Kolexia
Barthelemy Philippe Oncologie médicale
Barthelemy Philippe
Oncologie médicale
Hôpital Civil
Strasbourg, France
384 Activités
71 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Néphrocarcinome Tumeurs du rein Tumeurs de la prostate Tumeurs prostatiques résistantes à la castration Métastase tumorale Tumeurs du sein Tumeurs de la vessie urinaire Tumeurs du cerveau

Collaborateurs

Voir plus
Gross-Goupil Marine
Gross-Goupil Marine
Hôpital Saint-André, Bordeaux, France
Albiges Laurence
Albiges Laurence
Gustave-Roussy, Villejuif, France
Borchiellini Delphine
Borchiellini Delphine
Centre Antoine Lacassagne, Nice, France
Gravis-Mescam Gwenaelle
Gravis-Mescam Gwenaelle
Centre Paoli-Calmettes, Marseille, France

Industries

Voir plus
BMS
82 collaboration(s)
Dernière en 2023
A+A
70 collaboration(s)
Dernière en 2023
Ipsen
69 collaboration(s)
Dernière en 2023
Pfizer
39 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Analyse descriptive de la plus grande cohorte mondiale de patients atteints de CPRCm traités en accès précoce par [177Lu]Lu-PSMA-617
10e Journées Francophones de Médecine nucléaire - Biarritz   01 mars 2024
CaboCombo: A Prospective Observational International Study of Cabozantinib Tablets in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma in Adults
Essai Clinique (Ipsen)   27 février 2024
TROPHY U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer
Essai Clinique (Gilead)   20 février 2024
CheckMate 914: A Phase 3 Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab vs Placebo in Participants With Localized Renal Cell Carcinoma Who Underwent Radical or Partial Nephrectomy and Who Are at High Risk of Relapse
Essai Clinique (BMS)   12 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley): A Phase II, Multicenter, Randomized, Open Label, Parallel-Arm, Umbrella Study of Avelumab (MSB0010718C) in Combination With Other AntiTumor Agents as a Maintenance Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma Whose Disease Did Not Progress With First Line Platinum-Containing Chemotherapy (JAVELIN Bladder Medley)
Essai Clinique (Emd Serono)   05 février 2024
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
European journal of cancer (Oxford, England : 1990)   03 février 2024
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   23 janvier 2024
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Annals of oncology : official journal of the European Society for Medical Oncology   18 janvier 2024
KEYNOTE-B61: A Phase 2, Single-arm, Open-label Clinical Trial of Pembrolizumab Plus Lenvatinib in Participants With First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (nccRCC) (KEYNOTE-B61)
Essai Clinique (Merck & Co.)   12 janvier 2024